Pacific Shuanglin Bio-pharmacy Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000000F14
CNY
14.55
-0.2 (-1.36%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Pacific Shuanglin Bio-pharmacy Co., Ltd. stock-summary
stock-summary
Pacific Shuanglin Bio-pharmacy Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
607 Million
(Quarterly Results - Jun 2025)
Net Profit:
147 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CNY 15,851 Million (Large Cap)

stock-summary
P/E

25.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

1.95%

stock-summary
Debt Equity

-0.04

stock-summary
Return on Equity

8.12%

stock-summary
Price to Book

2.01